Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group
<p>Abstract</p> <p>Background</p> <p>Recent data in esophageal cancer suggests the variant allele of a single-nucleotide polymorphism (SNP) in <it>XRCC1 </it>may be associated with resistance to radiochemotherapy. However, this SNP has not been assessed in a...
Main Authors: | Wu Xifeng, Meltzer Stephen J, Liu Geoffrey, Offer Steven M, Hafez Michael J, Montgomery Elizabeth A, Powell Mark, Philips Santosh, Skaar Todd C, Murphy Kathleen M, Catalano Paul J, Yoon Harry H, Forastiere Arlene A, Benson Al B, Kleinberg Lawrence R, Gibson Michael K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/176 |
Similar Items
-
Definitive radiochemotherapy in esophageal cancer - a single institution experience
by: Anderluh Franc, et al.
Published: (2019-11-01) -
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
by: Victor Lewitzki, et al.
Published: (2019-12-01) -
Combined Radiochemotherapy: Metalloproteinases Revisited
by: Verena Waller, et al.
Published: (2021-05-01) -
High-dose-rate intraluminal brachytherapy prior
to external radiochemotherapy in locally advanced
esophageal cancer: preliminary results
by: Afsaneh Maddah Safaei, et al.
Published: (2017-01-01) -
Concurrent radiochemotherapy in advanced hypopharyngeal cancer
by: Lukarski Dusko, et al.
Published: (2010-05-01)